Design and synthesis of a potent, selective, brain penetrate PDE9 inhibitor as a potential treatment for Alzheimer's disease

被引：0
|
作者：
Kang, Zhijun [1 ]
Helal, Christopher J. [1 ]
Claffey, Michelle M. [1 ]
机构：
[1] Pfizer Inc, Neurosci Med Chem, Groton, CT 06340 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 241卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
56-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Novel, Highly Potent and Selective PDE9 Inhibitor for the Treatment of Sickle Cell Disease
    McArthur, James G.
    Maciel, Thiago
    Chen, Chunsheng
    Fricot, Aurelie
    Kobayashi, Dione
    Nguyen, Julia
    Phong Nguyen
    Parachova, Anna
    Abdulla, Fuad
    Vercellotti, Gregory M.
    Svenstrup, Niels
    Belcher, John D.
    BLOOD, 2016, 128 (22)
  • [2] Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer's disease
    Su, Tao
    Zhang, Tianhua
    Xie, Shishun
    Yan, Jun
    Wu, Yinuo
    Li, Xingshu
    Huang, Ling
    Luo, Hai-Bin
    SCIENTIFIC REPORTS, 2016, 6
  • [3] Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease
    Tao Su
    Tianhua Zhang
    Shishun Xie
    Jun Yan
    Yinuo Wu
    Xingshu Li
    Ling Huang
    Hai-Bin Luo
    Scientific Reports, 6
  • [4] The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents
    DeNinno, Michael P.
    Andrews, Melissa
    Bell, Andrew S.
    Chen, Yue
    Eller-Zarbo, Cynthia
    Eshelby, Nan
    Etienne, John B.
    Moore, Dianna E.
    Palmer, Michael J.
    Visser, Michael S.
    Yu, Li J.
    Zavadoski, William J.
    Gibbs, E. Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) : 2537 - 2541
  • [5] Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line
    Wunder, F
    Tersteegen, A
    Rebmann, A
    Erb, C
    Fahrig, T
    Hendrix, M
    MOLECULAR PHARMACOLOGY, 2005, 68 (06) : 1775 - 1781
  • [6] Identification of PDE9 clinical candidate PF-4447943 for the treatment of Alzheimer's disease utilizing prospective design and synthetic enablement
    Verhoest, Patrick
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [7] Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease
    Fiorito, Jole
    Saeed, Faisal
    Zhang, Hong
    Staniszewski, Agnieszka
    Feng, Yan
    Francis, Yitshak I.
    Rao, Sudha
    Thakkar, Devarshi M.
    Deng, Shi-Xian
    Landry, Donald W.
    Arancio, Ottavio
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 60 : 285 - 294
  • [8] Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
    Rabal, Obdulia
    Sanchez-Arias, Juan A.
    Cuadrado-Tejedor, Mar
    de Miguel, Irene
    Perez-Gonzalez, Marta
    Garcia-Barroso, Carolina
    Ugarte, Ana
    Estella-Hermoso de Mendoza, Ander
    Saez, Elena
    Espelosin, Maria
    Ursua, Susana
    Tan, Haizhong
    Wu, Wei
    Xu, Musheng
    Pineda-Lucena, Antonio
    Garcia-Osta, Ana
    Oyarzabal, Julen
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (09): : 4076 - 4101
  • [9] Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer?s disease
    Zhang, Pei
    Jiang, Mei-Yan
    Le, Mei-Ling
    Zhang, Bei
    Zhou, Qian
    Wu, Yinuo
    Zhang, Chen
    Luo, Hai-Bin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (14)
  • [10] Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer's Disease
    Khan, Mohd Shahnawaz
    Khan, Zuber
    Jabir, Nasimudeen R.
    Mehan, Sidharth
    Suhail, Mohd
    Zaidi, Syed Kashif
    Zughaibi, Torki A.
    Abid, Mohammad
    Tabrez, Shams
    MOLECULAR NEUROBIOLOGY, 2025, 62 (02) : 1558 - 1576
12345